Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet
- 28 December 2005
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 340 (4), 1111-1118
- https://doi.org/10.1016/j.bbrc.2005.12.121
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 41 references indexed in Scilit:
- Increased expression of PPARγ in high fat diet-induced liver steatosis in miceBiochemical and Biophysical Research Communications, 2005
- Involvement of MEK–ERK signaling pathway in the inhibition of cell growth by troglitazone in human pancreatic cancer cellsBiochemical and Biophysical Research Communications, 2005
- PPARγ2 regulates lipogenesis and lipid accumulation in steatotic hepatocytesAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cellsInternational Journal of Cancer, 2003
- The Peroxisome Proliferator-activated Receptor δ Promotes Lipid Accumulation in Human MacrophagesPublished by Elsevier BV ,2001
- Diabetic KKAy mice exhibit increased hepatic PPARγ1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinedionesJournal of Hepatology, 2001
- Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinedionesJCI Insight, 2000
- Activation of PPARγ inhibits cell growth and induces apoptosis in human gastric cancer cellsFEBS Letters, 1999
- Troglitazone action is independent of adipose tissue.JCI Insight, 1997
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Genes & Development, 1994